Clinical analysis of interstitial pneumonia after salvage treatment of ibrutinib combined with rituximab in elderly patients with refractory diffuse large B-cell lymphoma

HU Xiaojing; JIANG Yirong; LAI Yingchang; LI Zhangkun

doi:10.3969/j.issn.1009-0460.2022.07.009

Home>Articles>Clinical analysis of interstitial pneumonia after salvage treatment of ibrutinib combined with rituximab in elderly patients with refractory diffuse large B-cell lymphoma

DOI: 10.3969/j.issn.1009-0460.2022.07.009

Clinical analysis of interstitial pneumonia after salvage treatment of ibrutinib combined with rituximab in elderly patients with refractory diffuse large B-cell lymphoma

HU Xiaojing

JIANG Yirong

LAI Yingchang

LI Zhangkun

Machine-generated Keywords：

Publication Date：2022-07-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 628-632 )

Chinese Clinical Oncology

ISTICPKU

ISSN：1009-0460

Year, Vol.(Issue)：2022,27(7)